A detailed history of Skopos Labs, Inc. transactions in Cinemark Holdings, Inc. stock. As of the latest transaction made, Skopos Labs, Inc. holds 307 shares of CNK stock, worth $9,237. This represents 0.0% of its overall portfolio holdings.

Number of Shares
307
Previous 307 -0.0%
Holding current value
$9,237
Previous $7,000 28.57%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 14, 2025

SELL
$24.54 - $33.77 $1,251 - $1,722
-51 Reduced 16.61%
256 $7,000
Q1 2025

May 13, 2025

BUY
$23.74 - $33.06 $5,412 - $7,537
228 Added 288.61%
307 $7,000
Q4 2024

Jan 15, 2025

BUY
$26.69 - $36.02 $2,108 - $2,845
79 New
79 $2,000

Others Institutions Holding CNK

About Cinemark Holdings, Inc.


  • Ticker CNK
  • Exchange NYSE
  • Sector Communication Services
  • Industry Entertainment
  • Shares Outstandng 120,559,000
  • Market Cap $3.63B
  • Description
  • Cinemark Holdings, Inc., together with its subsidiaries, engages in the motion picture exhibition business. As of June 30, 2022, it operated 522 theatres with 5,868 screens in the United States, and South and Central America. The company was founded in 1984 and is headquartered in Plano, Texas.
More about CNK
Track This Portfolio

Track Skopos Labs, Inc. Portfolio

Follow Skopos Labs, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Skopos Labs, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Skopos Labs, Inc. with notifications on news.